CAMP and psoriasis: In psoriasis patients, LL‐37 has been recognized as an autoantigen that stimulates circulating T cells and contributes to the autoimmunity in these patients.78 As a similar autoimmune environment may obviously exist in PLE patients, it is likely that there are increased LL‐37‐specific T cells.